Literature DB >> 23344210

Breastfeeding, previous Epstein-Barr virus infection, Enterovirus 71 infection, and rural residence are associated with the severity of hand, foot, and mouth disease.

Yaping Li1, Shuangsuo Dang, Huiling Deng, Wenjun Wang, Xiaoli Jia, Ning Gao, Mei Li, Jun Wang.   

Abstract

Severe hand, foot, and mouth disease (HFMD) is likely to develop critical complications such as brainstem encephalitis, acute pulmonary edema, and circulatory failure, which cause child mortality during outbreaks. This study aims to investigate factors that predict the severity of HFMD. One hundred sixteen in-patient children with severe HFMD and 202 with mild HFMD were retrospectively enrolled. Potential factors were collected for each child including sex, age, residence, modes of delivery, birth weight, virus types causing HFMD, and virus exposure history. Univariate and multivariable logistic regression were used to determine which factors were associated with HFMD severity. In the univariate analysis, breastfeeding (OR 0.514, 95 % CI 0.309-0.856), rural residence (OR 1.971, 95 % CI 1.239-3.137), current Enterovirus 71 (EV71) infection (OR 2.539, 95 % CI 1.504-4.287), and previous Epstein-Barr virus (EBV) exposure (OR 3.136, 95 % CI 1.863-5.278) were each associated with the severity of HFMD. In the multivariate model, breastfeeding (OR 0.570, 95 % CI 0.332-0.980), rural residence (OR 1.973, 95 % CI 1.202-3.237), current EV71 infection (OR 2.290, 95 % CI 1.315-3.987), and previous EBV exposure (OR 2.550, 95 % CI 1.470-4.422) remained independently associated with the severity of HFMD. In conclusion, previous EBV exposure, EV71 infection, and rural residence are risk factors for severe HFMD; breastfeeding is a protective factor.

Entities:  

Mesh:

Year:  2013        PMID: 23344210     DOI: 10.1007/s00431-013-1939-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.860


  54 in total

1.  Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure.

Authors:  J A James; B R Neas; K L Moser; T Hall; G R Bruner; A L Sestak; J B Harley
Journal:  Arthritis Rheum       Date:  2001-05

2.  Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.

Authors:  A Ascherio; K L Munger; E T Lennette; D Spiegelman; M A Hernán; M J Olek; S E Hankinson; D J Hunter
Journal:  JAMA       Date:  2001-12-26       Impact factor: 56.272

3.  Hand-foot-and-mouth disease.

Authors:  D Kushner; B D Caldwell
Journal:  J Am Podiatr Med Assoc       Date:  1996-06

4.  Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications.

Authors:  S M Wang; C C Liu; H W Tseng; J R Wang; C C Huang; Y J Chen; Y J Yang; S J Lin; T F Yeh
Journal:  Clin Infect Dis       Date:  1999-07       Impact factor: 9.079

Review 5.  The immunological components of human milk and their effect on immune development in infants.

Authors:  Catherine J Field
Journal:  J Nutr       Date:  2005-01       Impact factor: 4.798

6.  Maternal antibodies in breast milk protect the child from enterovirus infections.

Authors:  Karita Sadeharju; Mikael Knip; Suvi M Virtanen; Erkki Savilahti; Sisko Tauriainen; Pentti Koskela; Hans K Akerblom; Heikki Hyöty
Journal:  Pediatrics       Date:  2007-05       Impact factor: 7.124

7.  Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene.

Authors:  Kok Keng Tee; Tommy Tsan-Yuk Lam; Yoke Fun Chan; Jon M Bible; Adeeba Kamarulzaman; C Y William Tong; Yutaka Takebe; Oliver G Pybus
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

Review 8.  Human enterovirus 71 and hand, foot and mouth disease.

Authors:  S S Y Wong; C C Y Yip; S K P Lau; K Y Yuen
Journal:  Epidemiol Infect       Date:  2010-01-08       Impact factor: 2.451

Review 9.  Breastfeeding and allergic disease: a multidisciplinary review of the literature (1966-2001) on the mode of early feeding in infancy and its impact on later atopic manifestations.

Authors:  J van Odijk; I Kull; M P Borres; P Brandtzaeg; U Edberg; L A Hanson; A Høst; M Kuitunen; S F Olsen; S Skerfving; J Sundell; S Wille
Journal:  Allergy       Date:  2003-09       Impact factor: 13.146

10.  Factors determining the outcome of children hospitalized with severe pneumonia.

Authors:  Karalanglin Tiewsoh; Rakesh Lodha; Ravindra M Pandey; Shobha Broor; M Kalaivani; Sushil K Kabra
Journal:  BMC Pediatr       Date:  2009-02-23       Impact factor: 2.125

View more
  5 in total

1.  [OAS1 gene polymorphism is associated with central nervous system involvement in children with enterovirus 71 infection].

Authors:  L I Yaping; Zhai Song; Wang Wenjun; Deng Huiling; L I Mei; Jia Xiaoli; Dang Shuangsuo
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-04-30

2.  The Epidemiology of Hand, Foot and Mouth Disease in Asia: A Systematic Review and Analysis.

Authors:  Wee Ming Koh; Tiffany Bogich; Karen Siegel; Jing Jin; Elizabeth Y Chong; Chong Yew Tan; Mark Ic Chen; Peter Horby; Alex R Cook
Journal:  Pediatr Infect Dis J       Date:  2016-10       Impact factor: 2.129

3.  Associations of Epstein-Barr Virus Infection with Attention Deficit Hyperactivity Disorder, Learning Disability, and Special Education in US Children.

Authors:  Jingjing Wang; Yaping Li; Xiaozhen Geng; Xin Zhang; Yanfeng Xiao; Wenjun Wang
Journal:  Int J Gen Med       Date:  2022-02-25

4.  Epidemiological characteristics, routine laboratory diagnosis, clinical signs and risk factors for hand, -foot -and -mouth disease: A systematic review and meta-analysis.

Authors:  Zhijie Yi; Shujun Pei; Wenshuai Suo; Xiaoyang Wang; Zengyuan Huang; Aihua Yi; Bohao Wang; Zhiquan He; Ruolin Wang; Yi Li; Wei Fan; Xueyong Huang
Journal:  PLoS One       Date:  2022-04-28       Impact factor: 3.240

Review 5.  The Risk Factors of Acquiring Severe Hand, Foot, and Mouth Disease: A Meta-Analysis.

Authors:  Bai Jun Sun; Hui Jie Chen; Ye Chen; Xiang Dong An; Bao Sen Zhou
Journal:  Can J Infect Dis Med Microbiol       Date:  2018-06-26       Impact factor: 2.471

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.